NMRA Neumora Corp: Bozor qiymatining balans qiymatiga nisbati
Neumora Therapeutics (NMRA) markaziy nerv tizimi patologiyalari uchun dori vositalarini ishlab chiqishga e'tibor qaratadi va ilk daromadga erishguniga qadar ichki rezervlarga tayanadi. Molekulalarni kashf qilish jarayoni 1.64 samaradorlik ko'rsatkichi bilan avtomatlashtirilgan biomateriallarni skrining qilish tizimlarini joriy etish orqali tezlashtirilmoqda. Aksiyalar narxining dinamikasi quyida keltirilgan; u kompaniyaning ekologik standartlarga sodiqligi va tibbiy tadqiqotlarni olib borishdagi etika bo'yicha ma'lumotlarni to'ldiradi.
Neumora (NMRA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Neumora Therapeutics|NMRA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics Inc|NMRA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Neumora Therapeutics Inc|NMRA - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzlari Neumora Therapeutics
Kompaniyaning har tomonlama tahlili:Neumora Therapeutics
Ushbu koeffitsiyent sof aktivlardan yuqori bo'lgan bozor premiumini o'lchaydi va biznes qiymatining uning balans qiymatidan qanchalik farqlanish darajasini aniqlaydi. Bozor kapitalizatsiyasining kitob aktivlariga nisbatini ko'rsatuvchi ushbu grafikni tahlil qilish orqali investor Neumora Therapeutics (NMRA) kompaniyasining depressiyani davolashga yondashuvidagi ma'lumotlar faniga oid metodikaga bo'lgan bozor kutganlarini ko'rishi mumkin, bunda yuqori premium bemorlarning neyron profilini aniqlashning potentsial aniqligini aks ettiradi.
Muhim raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|neurocrine.com (NBIX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals|Kapitallashuvning balans qiymatiga nisbati TRVI (trevitherapeutics.com)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|AVXL - Bozor qiymatining balans qiymatiga koeffitsiyenti|CeriBell Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Prothena PRTA|ALEC - Bozor qiymatining balans qiymatiga nisbati|annexonbio.com (ANNX) - Kapitallashuvning sof aktivlarga nisbati|omeros.com (OMER) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Neurogene Inc (NGNE)|Bozor qiymatining balans qiymatiga nisbati AC Immune Corp|VYGR: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SCLX|Bozor kapitallashuvining balans qiymatiga nisbati tevogen.com (TVGN)|Alpha Cognition Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati CGTX|IKT: Kapitallashuvning sof aktivlarga nisbati|Cassava Pharma - Bozor kapitallashuvining balans qiymatiga multiplikatori|ASRT: Bozor kapitallashuvining balans qiymatiga nisbati|Coya Therapeutics - Balans qiymatiga nisbatan bozor qiymati|VTGN (VistaGen Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Ovid Rx OVID|Bozor qiymatining balans qiymatiga nisbati Acumen Pharma (ABOS)|CRVO (CervoMed Corporation) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ATHE (Alterity Therapeutics Limited)|Bozor kapitallashuvining balans qiymatiga nisbati Clene Inc CLNN|PEPG - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi JUNS|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Annovis Bio Corporation (ANVS)|Kapitallashuvning sof aktivlarga nisbati GRCE|Bozor kapitallashuvining balans qiymatiga nisbati fireflyneuro.com|Kapitallashuvning sof aktivlarga nisbati KLTO (Klotho Neurosciences Inc)|Bozor kapitallashuvining balans qiymatiga multiplikatori NRSN|Bozor kapitallashuvining balans qiymatiga nisbati RVPH (Reviva Pharmaceuticals Holdings)|Balans qiymatiga nisbatan bozor kapitallashuvi MetaVia Inc. (MTVA)|NeurAxis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Helius Medical (HSDT) - Kapitallashuvning sof aktivlarga nisbati|passagebio.com (PASG) - Bozor qiymatining balans qiymatiga nisbati|NEUP - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp|Kapitallashuvning balans qiymatiga nisbati ATHA (Athira Pharma Corp)|Bozor qiymatining balans qiymatiga nisbati Addex Therapeutics (ADXN)|Kapitallashuvning sof aktivlarga nisbati alzamend.com ALZN|Bozor qiymatining balans qiymatiga nisbati Cyclerion Therapeutics, Inc. CYCN|Balans qiymatiga nisbatan bozor qiymati PTIX|Pasithea - Bozor kapitallashuvining balans qiymatiga nisbati|CRGT - Bozor kapitallashuvining balans qiymatiga nisbati|Avenue Therapeutics (ATXI) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati BCLI|CARA (Cara Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Chromocell Therapeutics Corp CHRO|Kapitallashuvning sof aktivlarga nisbati ELYM (Eliem Therapeutics)|Bozor kapitallashuvining balans qiymatiga nisbati intracellulartherapies.com (ITCI)|Bozor qiymatining balans qiymatiga nisbati Longboard Pharmaceuticals LBPH|Balans qiymatiga nisbatan bozor qiymati MRNS|NKGN - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti NeuroBo Pharmaceuticals Inc|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati SNPX|TRVN (Trevena, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Kapitallashuvning sof aktivlarga nisbati WENA (Anew Medical, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Cerevel Therapeutics Inc (CERE)